Insulin autoimmune syndrome caused by an adhesive skin patch containing loxoprofen-sodium

7Citations
Citations of this article
23Readers
Mendeley users who have this article in their library.

Abstract

A 62-year-old woman complained of repeated hypoglycemic events. A 75g oral glucose tolerance test (75 gOGTT) showed a marked increase in the plasma insulin level and impaired glucose tolerance. The patient exhibited a high titer of plasma anti-insulin autoantibodies. Her diagnosis was insulin autoimmune syndrome (IAS). Following the cessation of loxoprofen-sodium (LOXs), she experienced no further hypoglycemic episodes. However, the hypoglycemic attacks recurred following the accidental readministration of LOXs in an adhesive skin patch. Considering the changes in the titer of anti-insulin autoantibodies, the repeated 75 gOGTT and the repeated Scatchard analysis, we determined LOXs to be the cause of the IAS and evaluated the characteristics of the autoantibodies. © 2013 by The Japanese Society of Internal Medicine.

Cite

CITATION STYLE

APA

Okazaki-Sakai, S., Yoshimoto, S., Yagi, K., Wakasugi, T., Takeda, Y., & Yamagishi, M. (2013). Insulin autoimmune syndrome caused by an adhesive skin patch containing loxoprofen-sodium. Internal Medicine, 52(21), 2447–2451. https://doi.org/10.2169/internalmedicine.52.0570

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free